Evidence map›Paper›PMID 41346772›Full record

ArticleJournal of the advanced practitioner in oncology2025

Innovative Pathways for Advanced Practice Provider Growth: The Memorial Sloan Kettering Cancer Center Ascend Program.

Joanna Yohannes-Tomicich, Linda D'andrea, Xin Kenny Lin, Kelly Haviland, Nicole Zakak, Lindsey Przybilla

Abstract read
In one paragraph

Article in Journal of the advanced practitioner in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joanna Yohannes-TomicichFrom Department of Anesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Linda D'andreaDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Xin Kenny LinOutpatient Urology, Memorial Sloan Kettering Cancer Center, New York, New York.
Kelly HavilandNYU Langone Health, New York, New York.
Nicole ZakakMemorial Sloan Kettering Cancer Center, New York, New York.
Lindsey PrzybillaMemorial Sloan Kettering Cancer Center, New York, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: An advanced practice provider (APP) career advancement pathway was developed to promote clinical excellence, enhance job satisfaction, reduce turnover, and improve retention at a major metropolitan National Cancer Institute-designated comprehensive cancer center. Data Sources: A comprehensive literature search was conducted using the PubMed electronic database. Conclusions: The Memorial Sloan Kettering Cancer Center (MSKCC) Advance Model, MSK's APP Career Advancement Pathway of Excellence Theoretical Model, was established by integrating principles and tenants from the Strong Model of Advanced Practice Nursing and Benner's Novice to Expert model. It comprises seven domains of scholarly engagement: direct comprehensive care, research, drivers of change, education, publications and professional leadership, technology and innovation, and mentorship. The model serves as the foundation for the formal career pathway program known as the MSK Ascend Program. The MSK Ascend Program recognizes and honors APP engagement in professional development, establishes a structured pathway for recognition and promotion, and provides a foundation for the continuous development and advancement of APP practice at MSK. Implications: Leadership support and commitment are critical to the successful implementation and sustainability of the Ascend Program. This commitment continues to drive professional growth and satisfaction among APPs. The development and iterative refinement of the program exemplify adaptability and an enduring dedication to advancing the MSK APP community.

Identifiers

PMID41346772
PMCPMC12673992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.